La Jolla, CA, United States of America

Adriana Irimia

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Scripps Research Institute. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adriana Irimia. Retrieved from https://idiyas.com/inventor/adriana-irimia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adriana Irimia: Innovator in HIV Vaccine Design

Introduction

Adriana Irimia is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of vaccine design, particularly in the fight against HIV. Her innovative work has garnered attention and respect within the scientific community.

Latest Patents

Adriana holds a patent titled "Human Broadly Neutralizing Antibodies Against the Membrane-Proximal External Region of HIV Env for Vaccine Design and Intervention." This patent represents her groundbreaking research aimed at developing effective strategies for HIV prevention and treatment. She has 1 patent to her name, showcasing her commitment to advancing medical science.

Career Highlights

Adriana is affiliated with the Scripps Research Institute, where she collaborates with leading scientists in the field. Her work focuses on understanding the immune response to HIV and developing innovative approaches to vaccine design. Her research has the potential to change the landscape of HIV prevention.

Collaborations

Throughout her career, Adriana has worked alongside esteemed colleagues, including Michael Zwick and Lei Zhang. These collaborations have enriched her research and contributed to the advancement of knowledge in the field of immunology.

Conclusion

Adriana Irimia is a trailblazer in the realm of HIV vaccine research. Her dedication to innovation and collaboration positions her as a key figure in the ongoing battle against this global health challenge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…